(0.48%) 5 246.68 points
(0.32%) 39 558 points
(0.75%) 16 511 points
(0.73%) $78.59
(-0.30%) $2.34
(0.15%) $2 363.40
(0.29%) $28.79
(1.76%) $1 063.00
(0.00%) $0.924
(0.02%) $10.80
(-0.02%) $0.794
(0.01%) $91.33
Live Chart Being Loaded With Signals
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform...
Stats | |
---|---|
Today's Volume | 84 787.00 |
Average Volume | 801 845 |
Market Cap | 258.12M |
EPS | $0 ( 2024-03-26 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.05 |
ATR14 | $0.0430 (0.52%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-17 | Miller Mary | Sell | 558 | Common Stock |
2024-04-11 | Ra Capital Management, L.p. | Buy | 3 530 000 | Common Stock |
2024-04-11 | Perceptive Advisors Llc | Buy | 2 353 000 | Common Stock |
2024-03-04 | Palani Santhosh | Buy | 32 500 | Stock Option (Right to Buy) |
2024-03-04 | Palani Santhosh | Buy | 0 |
INSIDER POWER |
---|
25.44 |
Last 56 transactions |
Buy: 13 025 326 | Sell: 16 556 327 |
Volume Correlation
Acrivon Therapeutics, Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Acrivon Therapeutics, Correlation - Currency/Commodity
Acrivon Therapeutics, Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-536 000 (0.00 %) |
EPS: | $-2.74 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-536 000 (0.00 %) |
EPS: | $-2.74 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-1.10M (0.00 %) |
EPS: | $-1.350 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.260 |
Financial Reports:
No articles found.
Acrivon Therapeutics,
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's Acrivon Predictive Precision Proteomics, a precision medicine platform enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2, which is in a potentially registrational Phase 2 trial across various tumor types, including platinum-resistant ovarian, endometrial, and bladder cancer. The company is also developing its preclinical stage pipeline programs targeting critical nodes in the DNA damage response and cell cycle regulation pathways, such as WEE1, a protein kinase and PKMYT1, a protein serine/threonine kinase. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators